Search Results - Sebastian Stintzing

Refine Results
  1. 1
    Management of colorectal cancer

    Management of colorectal cancer by Sebastian Stintzing

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    TAS-102, a novel antitumor agent: A review of the mechanism of action

    TAS-102, a novel antitumor agent: A review of the mechanism of action by Heinz‐Josef Lenz, Sebastian Stintzing, Fotios Loupakis

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives

    Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives by Julian Walter Holch, Sebastian Stintzing, Volker Heinemann

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets

    Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets by Daniel Neureiter, Sebastian Stintzing, Tobias Kiesslich, Matthias Ocker

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes

    Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes by Sebastian Stintzing, Sabine Tejpar, Peter Gibbs, Lars Thiebach, Heinz‐Josef Lenz

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer

    ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer by Loredana Vecchione, Sebastian Stintzing, George Pentheroudakis, Jean-Yves Douillard, Florian Lordick

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone

    Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone by Bengt Glimelius, Sebastian Stintzing, John L. Marshall, Takayuki Yoshino, Aimery de Gramont

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer

    Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer by Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin Raftery, Gabriele Pecher

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer

    Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer by Jörg Trojan, Sebastian Stintzing, Oliver Haase, Christine Koch, Paul Ziegler, Melanie Demes, Ivan Jelas

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation

    Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation by Dino Bekric, Matthias Ocker, Christian Mayr, Sebastian Stintzing, Markus Ritter, Tobias Kiesslich, Daniel Neureiter

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer

    Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer by Chiara Cremolini, Clara Montagut, Philippe Ronga, Filippo Venturini, Kensei Yamaguchi, Sebastian Stintzing, Alberto Sobrero

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors

    Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors by Jesús García‐Foncillas, Yu Sunakawa, Dan Aderka, Zev A. Wainberg, Philippe Ronga, Pauline Witzler, Sebastian Stintzing

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials

    Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials by Clemens Gießen, Ruediger P. Laubender, Donna P. Ankerst, Sebastian Stintzing, Dominik Paul Modest, Ulrich Mansmann, Volker Heinemann

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AIO KRK 0104 trial

    Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AI... by Dominik Paul Modest, Ruediger P. Laubender, Sebastian Stintzing, Clemens Gießen, Christoph Schulz, Michael Haas, Ulrich Mansmann, Volker Heinemann

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer

    A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type me... by Volker Heinemann, Fernando Rivera, Bert H. O’Neil, Sebastian Stintzing, Reija Koukakis, Jan-Henrik Terwey, Jean‐Yves Douillard

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer

    Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer by Martin Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens‐Uwe Blohmer, Gabriele Pecher

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer

    Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer by Sabine Tejpar, Sebastian Stintzing, Fortunato Ciardiello, Josep Tabernero, Eric Van Cutsem, Frank Beier, Regina Esser, Heinz‐Josef Lenz, Volker Heinemann

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer

    Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer by Richard M. Goldberg, Clara Montagut, Zev A. Wainberg, Philippe Ronga, Françis Audhuy, Julien Taı̈eb, Sebastian Stintzing, Salvatore Siena, Daniele Santini

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan‐based randomized first‐line trial

    Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan‐based randomized first‐line trial by Clemens Gießen, Ruediger P. Laubender, Ludwig Fischer von Weikersthal, Andreas Schalhorn, Dominik Paul Modest, Sebastian Stintzing, Michael Haas, Ulrich Mansmann, Volker Heinemann

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: Results from a randomized trial of the GERMAN AIO CRC Study Group

    Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal tran... by Sebastian Stintzing, Christine Kapaun, Rüdiger P. Laubender, Andreas Jung, Jens Neumann, Dominik Paul Modest, Clemens Gießen, Nicolas Moosmann, Andreas Wollenberg, Thomas Kirchner, Volker Heinemann

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: